50
Participants
Start Date
July 31, 2018
Primary Completion Date
December 31, 2019
Study Completion Date
December 31, 2019
Gabapentin
This double blinded randomized control trial will enroll 50 children age 3-18 years, undergoing T/As. Patients will be receiving either one gabapentin dose (15mg/kg up to 600mg) or placebo preoperatively. Both control and test group will receive the standard narcotic regimen intraoperatively.
RECRUITING
Children's Healthcare of Atlanta, Atlanta
Lead Sponsor
Children's Healthcare of Atlanta
OTHER